The recent coronavirus pandemic shows just how quickly a deadly pathogen can sweep across the globe, killing tens of thousands in the U.S. and disrupting daily life for millions more in the span of a few months.

Artificial intelligence helps researchers identify metabolites, the small molecules that underlie life.

A PNNL scientist is studying the structures of the proteins on the surface of the novel coronavirus, using NMR spectroscopy to reveal information about the molecular toolkit that holds the keys to a vaccine or treatment.

Combining its strength in biological sciences and data analytics, researchers at the Department of Energy's PNNL are working to enable a quick response to a biological incident — whether intentional, accidental or natural.

A new study focusing on the proteins involved in endometrial cancer, commonly known as uterine cancer, offers insights about which patients will need aggressive treatment and which won’t.

The researchers treated human pancreatic islets with substances produced by the body and thought to be involved in the diabetes disease process.

While it’s one small step forward for mouse research, it’s a big step forward for understanding proteins, the molecular workhorses in biological organisms.

PNNL’s Intelligent Load Control technology manages and adjusts electricity use in buildings when there’s peak demand on the power grid.

Pumped-storage hydropower offers the most cost-effective storage option for shifting large volumes of energy. A PNNL-led team wrote a report comparing cost and performance factors for 10 storage technologies.

A new drug delivery method designed by researchers at PNNL and Washington State University (WSU) has shown it can target and kill lung cancer cells.

PNNL researchers are developing the only tool that can control large-scale distributed energy resources in real time.

The first phase, which started in 2014, generated foundational data from developing mouse and human lungs, created a web portal for public data sharing, and established a repository of human lung tissues.

When two powerful earthquakes rocked southern California earlier this month, officials’ attention focused, understandably, on safety. How many people were injured? Were buildings up to code? How good are we at predicting earthquakes?

Scientists have taken one of the most detailed looks ever at levels of soluble amyloid beta in the brain.

PNNL scientist Wei-Jun Qian and colleagues have contributed to a study that offers clues for delaying or even preventing the autoimmune attack that’s at the core of type-1 diabetes.

PNNL researchers today published a pair of papers, in Cell and in Nature, exploring the effects of the gut microbiome on our health, including autism, brain function, and inflammatory bowel disease.

He is being recognized for his contributions involving various kinds of separations with mass spectrometry (MS).

His patents involve novel MS and IMS technologies that, in the end, have enabled a deeper understanding of living systems.

PNNL researchers have devised a way to measure and distinguish tiny amounts of phosphorylated proteins, an approach that could be used in research to help treat diseases such as diabetes and cancer.

The structure of a fundamental electrical switch in the brain has been revealed, thanks to PNNL researchers working together with counterparts at Oregon Health & Science University (OHSU).